Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01422889
Other study ID # S2065
Secondary ID
Status Completed
Phase N/A
First received August 22, 2011
Last updated January 6, 2016
Start date September 2011
Est. completion date February 2015

Study information

Verified date January 2016
Source Boston Scientific Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.


Description:

The ION™ stent is the third-generation Boston Scientific (BSC) paclitaxel-eluting coronary stent. It is designed for improved performance specific to deliverability and radio-opacity while maintaining a similar drug release profile of the TAXUS Express and TAXUS Liberté stents. Following PMA approval from the FDA for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System the ION US Post-Approval study will compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice. Post-approval studies of drug-eluting stents (DES) provide an opportunity to observe and assess patient outcomes and technology performance in a real-world setting.


Recruitment information / eligibility

Status Completed
Enrollment 1120
Est. completion date February 2015
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 110 Years
Eligibility Inclusion Criteria:

Consented subjects receiving one or more ION(TM)Coronary Stents

Exclusion Criteria:

Subjects not clinically indicated to receive an ION (TM)Coronary Stent

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Device:
ION™ Coronary Stent System
This study is intended to evaluate the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System across a range of institutions and physician users to observe and assess subject outcomes and technology performance in a real-world setting.

Locations

Country Name City State
United States King's Daughters Medical Center - Kentucky Heart Inst Ashland Kentucky
United States Bakersfield Memorial Hospital Bakersfield California
United States Union Memorial Hospital Baltimore Maryland
United States Tufts Medical Center Boston Massachusetts
United States Kootenai Medical Center Coeur d'Alene Idaho
United States Sisters of Charity Providence Hospital Columbia South Carolina
United States Ohio State University Medical Center Columbus Ohio
United States Riverside Methodist Hospital Columbus Ohio
United States Baylor Heart & Vascular Hospital Dallas Texas
United States CRSTI/Medical City Dallas Dallas Texas
United States Memorial Hospital at Gulfport Gulfport Mississippi
United States Our Lady of Lourdes Medical Center Haddon Heights New Jersey
United States Indiana Heart Hospital Indianapolis Indiana
United States Krannert Institute of Cardiology Indianapolis Indiana
United States Regional Hospital Jackson Tennessee
United States NEA Baptist Memorial Hospital Jonesboro Arkansas
United States St. Bernard's Medical Center Jonesboro Arkansas
United States Freeman West Hospital Joplin Missouri
United States Kingwood Medical Center Hospital Kingwood Texas
United States Sparrow Health System - Sparrow Hospital Lansing Michigan
United States St. Joseph's Hospital Health Center Liverpool New York
United States Meriter Hospital, Inc. Madison Wisconsin
United States Grand Strand Regional Medical Center Myrtle Beach South Carolina
United States Centennial Medical Center Nashville Tennessee
United States Oklahoma Heart Hospital Oklahoma City Oklahoma
United States Northern Michigan Hospital Petoskey Michigan
United States Maine Medical Center Portland Maine
United States Wake Medical Center Raleigh North Carolina
United States Redmond Regional Medical Center Rome Georgia
United States Methodist Texsan Hospital San Antonio Texas
United States Alvarado Hospital San Diego California
United States Jersey Shore University Medical Center Sea Girt New Jersey
United States Lakeland Hospitals at St. Joseph St. Joseph Michigan
United States Northside Hospital and Heart Institute St. Petersburg Florida
United States University Community Hospital Tampa Florida
United States Mercy St. Vincent Medical Center Toledo Ohio
United States St. Elizabeth Medical Center Utica New York
United States CaRE Foundation, Inc. Wausau Wisconsin
United States Iowa Heart Center West Des Moines Iowa
United States St. Mary Medical Center Yardley Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Boston Scientific Corporation

Country where clinical trial is conducted

United States, 

References & Publications (2)

Cannon L, Kimmelstiel CD, Kellett M, White A, Hill R, Grady T, Myers PR, Underwood P, Dawkins KD. One-year real-world outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Primary endp

Kimmelstiel CD, Cannon LA, Jobe RL, Stoler R, Pow T, Ganim R, Kayser R, Allocco DJ, Dawkins KD. Two-Year "Real-World" Outcomes Following Implantation of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent in Routine Clinical Practice: Results Fro

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac Death or Myocardial Infarction (CD/MI) Cardiac Death or myocardial infarction (CD/MI) in the ION registry population. For the protocol specified primary endpoint analysis including data pooled from the PERSEUS SV, PERSEUS WH and TE Prove patient populations please see the citations. 12 Months Yes
Secondary Stent Thrombosis Academic Research Consortium (ARC) defined (definite/probable) stent thrombosis (ST) in the ION registry population. For the protocol specified secondary endpoint analysis including data pooled from the PERSEUS SV, PERSEUS WH and TE Prove patient populations please see the citations. Annually, after the first year, through 2 years. Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions N/A